Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$165.67 - $199.94 $3.05 Million - $3.68 Million
-18,396 Reduced 90.82%
1,859 $314,000
Q4 2023

Feb 01, 2024

SELL
$151.44 - $200.09 $2.47 Million - $3.27 Million
-16,322 Reduced 44.62%
20,255 $4 Million
Q3 2023

Oct 31, 2023

BUY
$167.14 - $192.77 $66,521 - $76,722
398 Added 1.1%
36,577 $6.36 Million
Q2 2023

Jul 31, 2023

BUY
$160.94 - $186.23 $716,504 - $829,095
4,452 Added 14.03%
36,179 $6.23 Million
Q4 2022

Feb 08, 2023

BUY
$131.14 - $157.47 $1,049 - $1,259
8 Added 0.03%
31,727 $4.65 Million
Q3 2022

Oct 31, 2022

BUY
$148.29 - $182.55 $1.54 Million - $1.89 Million
10,370 Added 48.57%
31,719 $4.7 Million
Q2 2022

Aug 09, 2022

BUY
$155.97 - $200.09 $3.12 Million - $4 Million
20,001 Added 1483.75%
21,349 $3.67 Million
Q1 2022

Apr 26, 2022

BUY
$181.39 - $234.03 $1,995 - $2,574
11 Added 0.82%
1,348 $254,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $258,963 - $330,279
1,337 New
1,337 $267,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.